Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy
JAMA Network Open | July 22, 2021 | Volume: 4 | Issue: 7 | Pages: e2116536
10.1001/jamanetworkopen.2021.16536
| PMID 34292336